<VariationArchive RecordType="classified" VariationID="1707498" VariationName="NM_000168.6(GLI3):c.2632del (p.Glu878fs)" VariationType="Deletion" Accession="VCV001707498" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2022-10-08" DateCreated="2022-10-01" MostRecentSubmission="2022-10-01">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="1705803" VariationID="1707498">
      <GeneList>
        <Gene Symbol="GLI3" FullName="GLI family zinc finger 3" GeneID="2737" HGNC_ID="HGNC:4319" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>7p14.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41960949" stop="42264268" display_start="41960949" display_stop="42264268" Strand="-" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="42000546" stop="42276617" display_start="42000546" display_stop="42276617" Strand="-" />
          </Location>
          <OMIM>165240</OMIM>
          <Haploinsufficiency last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2021-01-12" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=GLI3">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_000168.6(GLI3):c.2632del (p.Glu878fs)</Name>
      <CanonicalSPDI>NC_000007.14:41966440:C:</CanonicalSPDI>
      <VariantType>Deletion</VariantType>
      <Location>
        <CytogeneticLocation>7p14.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="7" Accession="NC_000007.14" start="41966441" stop="41966441" display_start="41966441" display_stop="41966441" variantLength="1" positionVCF="41966440" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="7" Accession="NC_000007.13" start="42006039" stop="42006039" display_start="42006039" display_stop="42006039" variantLength="1" positionVCF="42006038" referenceAlleleVCF="TC" alternateAlleleVCF="T" />
      </Location>
      <ProteinChange>E878fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000168.6" sequenceAccession="NM_000168" sequenceVersion="6" change="c.2632delG" MANESelect="true">
            <Expression>NM_000168.6:c.2632delG</Expression>
          </NucleotideExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.13" sequenceAccession="NC_000007" sequenceVersion="13" change="g.42006039del" Assembly="GRCh37">
            <Expression>NC_000007.13:g.42006039del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000007.14" sequenceAccession="NC_000007" sequenceVersion="14" change="g.41966441del" Assembly="GRCh38">
            <Expression>NC_000007.14:g.41966441del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008434.1" sequenceAccession="NG_008434" sequenceVersion="1" change="g.275580del">
            <Expression>NG_008434.1:g.275580del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_008434.2" sequenceAccession="NG_008434" sequenceVersion="2" change="g.302827del">
            <Expression>NG_008434.2:g.302827del</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_000168.6" sequenceAccession="NM_000168" sequenceVersion="6" change="c.2632del" MANESelect="true">
            <Expression>NM_000168.6:c.2632del</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_000159.3" sequenceAccession="NP_000159" sequenceVersion="3" change="p.Glu878fs">
            <Expression>NP_000159.3:p.Glu878fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_000168.6(GLI3):c.2632del (p.Glu878fs) AND Pallister-Hall syndrome" Accession="RCV002286458" Version="1">
        <ClassifiedConditionList TraitSetID="3814">
          <ClassifiedCondition DB="MedGen" ID="C0265220">Pallister-Hall syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-09-24" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-09-24" NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2022-10-01" MostRecentSubmission="2022-10-01">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="3814" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="3351" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">Pallister-Hall syndrome</ElementValue>
                <XRef ID="Pallister-Hall+syndrome/5543" DB="Genetic Alliance" />
                <XRef ID="MONDO:0007804" DB="MONDO" />
                <XRef ID="56677004" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hypothalamic hamartoblastoma, hypopituitarism, imperforate anus, and postaxial polydactyly</ElementValue>
              </Name>
              <Symbol>
                <ElementValue Type="Preferred">PHS</ElementValue>
                <XRef Type="MIM" ID="146510" DB="OMIM" />
              </Symbol>
              <Symbol>
                <ElementValue Type="Alternate">PHS1</ElementValue>
              </Symbol>
              <AttributeSet>
                <Attribute Type="public definition">GLI3-related Pallister-Hall syndrome (GLI3-PHS) is characterized by a spectrum of anomalies ranging from polydactyly, asymptomatic bifid epiglottis, and hypothalamic hamartoma at the mild end to laryngotracheal cleft with neonatal lethality at the severe end. Individuals with mild GLI3-PHS may be incorrectly diagnosed as having isolated postaxial polydactyly type A. Individuals with GLI3-PHS can have pituitary insufficiency and may die as neonates from undiagnosed and untreated adrenal insufficiency.</Attribute>
                <XRef ID="NBK1465" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7305" />
                <XRef ID="7305" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301638</ID>
                <ID Source="BookShelf">NBK1465</ID>
              </Citation>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301753</ID>
                <ID Source="BookShelf">NBK5192</ID>
              </Citation>
              <XRef ID="672" DB="Orphanet" />
              <XRef ID="C0265220" DB="MedGen" />
              <XRef ID="MONDO:0007804" DB="MONDO" />
              <XRef Type="MIM" ID="146510" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="5036960" SubmissionDate="2022-09-29" DateLastUpdated="2022-10-01" DateCreated="2022-10-01">
        <ClinVarSubmissionID localKey="SUB12111191" submittedAssembly="GRCh37" title="SUB12111191" />
        <ClinVarAccession Accession="SCV002576309" DateUpdated="2022-10-01" DateCreated="2022-10-01" Type="SCV" Version="1" SubmitterName="Gemeinschaftspraxis fuer Humangenetik Dresden" OrgID="508479" OrganizationCategory="laboratory" OrgAbbreviation="GP fuer Humangenetik DD" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-09-24">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This variant is not reported in HGMD 2022.2, gnomAD (v2.1.1), dbSNP (v154) or LOVD. Mutations in GLI3 are known to be causal for Greig cephalopolysyndactyly syndrome (OMIM 175700), Pallister-Hall syndrome (OMIM 146510) and Polydactyly (OMIM 174200, 174700). Due to the protein truncating character the variant is classified as pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="ModeOfInheritance">Autosomal dominant inheritance</Attribute>
        </AttributeSet>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation Type="general">
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
              <Gender>female</Gender>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="SingleHeterozygote" integerValue="1" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="GLI3">
              <Name>GLI family zinc finger 3</Name>
            </Gene>
          </GeneList>
          <VariantType>Variation</VariantType>
          <Location>
            <GeneLocation>NM_000168.6:exon 15</GeneLocation>
          </Location>
          <AttributeSet>
            <Attribute Type="HGVS">NM_000168.6:c.2632delG</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="146510" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12111191</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="5036960" TraitType="Disease" MappingType="XRef" MappingValue="146510" MappingRef="OMIM">
        <MedGen CUI="C0265220" Name="Pallister-Hall syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

